GNRC vs. ABBV

Last updated Apr 2, 2026

Compare and contrast key facts about Generac Holdings Inc. (GNRC) and AbbVie Inc. (ABBV).

Performance

GNRC vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Generac Holdings Inc. (GNRC) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

GNRC vs. ABBV - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
GNRC Generac Holdings Inc.	45.96%	-12.05%	19.97%	28.39%	-71.40%	54.75%	126.08%	102.39%	0.36%	21.55%
ABBV AbbVie Inc.	-5.16%	33.08%	18.86%	-0.23%	24.01%	32.43%	27.72%	1.47%	-0.96%	60.07%

Fundamentals

Market Cap GNRC : $11.60B ABBV : $381.37B
EPS GNRC : $2.71 ABBV : $2.38
PE Ratio GNRC : 73.52 ABBV : 90.18
PS Ratio GNRC : 2.79 ABBV : 6.23
Total Revenue (TTM) GNRC : $4.21B ABBV : $61.16B
Gross Profit (TTM) GNRC : $1.61B ABBV : $44.85B
EBITDA (TTM) GNRC : $414.88M ABBV : $28.29B

Returns By Period

In the year-to-date period, GNRC achieves a 45.96% return, which is significantly higher than ABBV's -5.16% return. Both investments have delivered pretty close results over the past 10 years, with GNRC having a 18.12% annualized return and ABBV not far ahead at 18.93%.

GNRC

• 1D: 1.90%
• 1M: -13.60%
• YTD: 45.96%
• 6M: 18.56%
• 1Y: 57.56%
• 3Y*: 22.60%
• 5Y*: -9.27%
• 10Y*: 18.12%

ABBV

• 1D: -1.15%
• 1M: -8.23%
• YTD: -5.16%
• 6M: -10.68%
• 1Y: 7.72%
• 3Y*: 14.56%
• 5Y*: 19.12%
• 10Y*: 18.93%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

GNRC vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GNRC

GNRC Risk / Return Rank: 73
GNRC Sharpe Ratio Rank: 76
GNRC Sortino Ratio Rank: 74
GNRC Omega Ratio Rank: 72
GNRC Calmar Ratio Rank: 73
GNRC Martin Ratio Rank: 71

ABBV

ABBV Risk / Return Rank: 47
ABBV Sharpe Ratio Rank: 51
ABBV Sortino Ratio Rank: 43
ABBV Omega Ratio Rank: 43
ABBV Calmar Ratio Rank: 50
ABBV Martin Ratio Rank: 50

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GNRC vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Generac Holdings Inc. (GNRC) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	GNRC	ABBV	Difference
Sharpe ratio Return per unit of total volatility	1.11	0.29	+0.83
Sortino ratio Return per unit of downside risk	1.83	0.56	+1.27
Omega ratio Gain probability vs. loss probability	1.23	1.08	+0.16
Calmar ratio Return relative to maximum drawdown	1.74	0.36	+1.38
Martin ratio Return relative to average drawdown	3.90	0.80	+3.10
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

GNRC vs. ABBV - Sharpe Ratio Comparison

The current GNRC Sharpe Ratio is 1.11, which is higher than the ABBV Sharpe Ratio of 0.29. The chart below compares the historical Sharpe Ratios of GNRC and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	GNRC	ABBV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.11	0.29	+0.83
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.18	0.85	-1.03
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.41	0.74	-0.33
Sharpe Ratio (All Time) Calculated using the full available price history	0.28	0.74	-0.46

Correlation

The correlation between GNRC and ABBV is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

GNRC vs. ABBV - Dividend Comparison

GNRC has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 3.09%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
GNRC Generac Holdings Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ABBV AbbVie Inc.	3.09%	2.87%	3.49%	3.82%	3.49%	3.84%	4.41%	4.83%	3.89%	2.65%	3.64%	3.41%

Drawdowns

GNRC vs. ABBV - Drawdown Comparison

The maximum GNRC drawdown since its inception was -83.75%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for GNRC and ABBV.

Drawdown Indicators

	GNRC	ABBV	Difference
Max Drawdown Largest peak-to-trough decline	-83.75%	-45.09%	-38.66%
Max Drawdown (1Y) Largest decline over 1 year	-32.77%	-16.31%	-16.46%
Max Drawdown (5Y) Largest decline over 5 years	-83.75%	-21.92%	-61.83%
Max Drawdown (10Y) Largest decline over 10 years	-83.75%	-45.09%	-38.66%
Current Drawdown Current decline from peak	-60.65%	-10.68%	-49.97%
Average Drawdown Average peak-to-trough decline	-37.56%	-10.70%	-26.86%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.66%	7.58%	+7.08%

Volatility

GNRC vs. ABBV - Volatility Comparison

Generac Holdings Inc. (GNRC) has a higher volatility of 13.21% compared to AbbVie Inc. (ABBV) at 7.61%. This indicates that GNRC's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	GNRC	ABBV	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.21%	7.61%	+5.60%
Volatility (6M) Calculated over the trailing 6-month period	36.72%	18.69%	+18.03%
Volatility (1Y) Calculated over the trailing 1-year period	51.90%	27.07%	+24.83%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	51.42%	22.62%	+28.80%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	44.54%	25.70%	+18.84%

Financials

GNRC vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between Generac Holdings Inc. and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

GNRC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Generac Holdings Inc. reported a gross profit of 396.08M and revenue of 1.09B. Therefore, the gross margin over that period was 36.3%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported a gross profit of 13.96B and revenue of 16.62B. Therefore, the gross margin over that period was 84.0%.

GNRC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Generac Holdings Inc. reported an operating income of -9.32M and revenue of 1.09B, resulting in an operating margin of -0.9%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported an operating income of 5.81B and revenue of 16.62B, resulting in an operating margin of 35.0%.

GNRC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Generac Holdings Inc. reported a net income of -24.46M and revenue of 1.09B, resulting in a net margin of -2.2%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported a net income of 1.82B and revenue of 16.62B, resulting in a net margin of 10.9%.